The DOI matches its Crossref record; 346 of the 347 references it cites were found in a registry or an index.
Specificity, versatility, and control of TGF-β family signaling
Open accessAbstract
Molecular function and pathway cross-talk in TGF-β signaling reveal its complexity and open questions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they need to effectively interfere with the very high binding affinity (10−11 M range) of TGF-β to cell surface receptor complexes65.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [65]
In the citing paper
“By design, these chimeras, based on the TβRII ligand trap, should sequester TGF-β1 and -β3 only, similarly to dimerized TβRII receptor65.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · cited 1×
“On the basis of sequence characteristics, the type I and type II receptors are predicted dual-specificity kinases, able to phosphorylate on serine and threonine, as well as tyrosine, and are phylogenetically clustered proximal to other dual-specificity kinases such asMEK kinases (65, 66).”
BackgroundMolecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Self-citationmTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,239
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Smad transcription factorsPreprint
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,519
Swatek, K. N., & Komander, D. (2016) · Cell Research · doi:10.1038/cr.2016.39 · Cited by 2,141
mTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.03.035 · Cited by 2,112 · cited 1×
“12, eaav5183 (2019) 26 February 2019 rylates and thus activates mTOR, which, among other responses, promotes protein synthesis and cell metabolism, is required for cell migration, and phosphorylates AKT in a positive feedback loop (311, 312).”
BackgroundSPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Self-citation
Flagged first, then by citations
1 of the 347 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- R. Derynck K. Miyazono The Biology of the TGF-β Family (Cold Spring Harbor Laboratory Press 2017) pp. 1164.
Cited by
Sorted by citations
Items 301–400 of 797
Effects of embryonic origin, tissue cues and pathological signals on fibroblast diversity in humans
Torregrossa, M., Davies, L. C., Machens, H., Simon, J. C., Franz, S., & Rinkevich, Y. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01638-5 · Cited by 19
“A key driver of this process is TGFβ, which activates various pathways, including SMAD, MAPK–ERK and PI3K– AKT–mTOR 104 .”
Aghaei, M., Bahreiny, S. S., Mahdizade, A. H., Abbasi, A., Magharati, A., & Avarvand, A. Y. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02066-x · Cited by 22
“Intriguingly, it promotes the differentiation of APCs and enhances the activation of CD8 + T-cells [162 ].”
Myoneurin regulates BMP signaling by competing with Ppm1a for Smad binding
Yang, S., Ning, G., Hou, Y., Cao, Y., Xu, J., Wu, J., Zhang, T., & Wang, Q. (2022) · iScience · doi:10.1016/j.isci.2022.104495 · Cited by 17
“Given this, we hypothesized that Mynn regulates BMP signaling by interacting with Smad proteins, which constitutively shuttle between the cytoplasm and nucleus (Derynck and Budi, 2019).”
BackgroundInfluentialSmall extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis
Zhao, Y., Yu, Y., Wang, S., Li, J., & Teng, L. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.07.004 · Cited by 17
The role of miRNA molecules in the miscarriage process
Omeljaniuk, W. J., Laudański, P., & Miltyk, W. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad047 · Cited by 17
“In addition, as a multifunctional cytokine, TGF-β1 is widely involved in the regulation of immune cell function and plays an indispensable role in fetal–maternal immune tolerance [67, 71].”
BackgroundManipulating TGF-β signaling to optimize immunotherapy for cervical cancer
Yin, S., Cui, H., Qin, S., & Yu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115355 · Cited by 18
GDF1 ameliorates cognitive impairment induced by hearing loss
Pan, L., Li, C., Meng, L., Zhang, G., Zou, L. B., Tian, Y., Chen, S., Sun, Y., Su, D., Zhang, X., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00592-5 · Cited by 18
“GDF1 is a member of the transforming growth factor-β (TGFβ) superfamily, which participates in cytokine ‒ cytokine receptor interactions and the regulation of Akt signaling 33,34 .”
Structure, unique biological properties, and mechanisms of action of transforming growth factor β
Zelisko, N., Lesyk, R., & Stoika, R. S. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107611 · Cited by 18
Sundqvist, A., Voytyuk, O., Hamdi, M., Popeijus, H. E., van der Burgt, C., Janssen, J. M., Martens, J. W. M., Moustakas, A., Heldin, C., ten Dijke, P., et al. (2019) · Cells · doi:10.3390/cells8121481 · Cited by 17
“TGFβ signaling via membrane-localized TBRI and TBRII triggers phosphorylation and activation of Smad2 and 3, and thereby can both directly and indirectly induce TGFβ target genes controlled by Smad and/or AP-1 sites [1,2].”
BackgroundBoby, N., Ransom, A. L., Pace, B. T., Williams, K. M., Mabee, C., Das, A., Srivastav, S., Porter, E. M., & Pahar, B. (2021) · Cells · doi:10.3390/cells10040806 · Cited by 17
“The active form of TGF-β1 exerts its biological effects by either SMAD-independent or SMAD-dependent pathway [5,6].”
BackgroundPhosphoinositide-binding activity of Smad2 is essential for its function in TGF-β signaling
Buwaneka, P., Ralko, A. A., Gorai, S., Pham, H. T. T., & Cho, W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101303 · Cited by 16
“It has been generally thought that Smad2 is recruited to the activated TGF-β receptor complex through the Smad2-TβRI interaction (1, 2) (see Fig.”
BackgroundInfluentialRaja, E., Morikawa, M., Nishida, J., Tanabe, R., Takahashi, K., Seeherman, H. J., Saito, N., Todo, T., & Miyazono, K. (2019) · Cancer Science · doi:10.1111/cas.14187 · Cited by 17
Sinha, S. K., Carpio, M. B., & Nicholas, S. B. (2024) · Biomedicines · doi:10.3390/biomedicines12102209 · Cited by 19
“TGF-β 1 activates SMAD-3 by phosphorylation, regulating the transcription of target genes, including those that control ECM proteins [130,133,134] (Figure 3).”
BackgroundThe Impact of Klotho in Cancer: From Development and Progression to Therapeutic Potential
Ortega, M. A., Boaru, D. L., León-Oliva, D. D., Castro-Martinez, P. D., Minaya‐Bravo, A., Casanova-Martín, C., Barrena-Blázquez, S., Montero, C. G., Fraile‐Μartinez, O., López-González, L., et al. (2025) · Genes · doi:10.3390/genes16020128 · Cited by 18
“This interaction can also trigger the action of non-canonical pathways, including the JNK, p38, MAPK, PI3K/Akt, Rho-like GTPase, and NF-κ B pathways [72–74].”
Yin, W., Yang, Y., Yue, Z., Wang, R., Bai, L., Lin, Y., Chen, X., & Cai, X. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123780 · Cited by 17
Unveiling the dimer/monomer propensities of Smad MH1-DNA complexes
Ruiz, L., Kaczmarska, Z., Gomes, T., Aragón, E., Torner, C., Freier, R., Bagiński, B., Martín-Malpartida, P., Garrido, N. D. M., Márquez, J. A., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.044 · Cited by 16
“For instance, trimeric complexes containing BMP-Smad homotrimers or Smad4/TGFb-Smad/BMP-Smad heterotrimers have never been detected in cells [21,27,32].”
BackgroundMasuzawa, R., Takahashi, K., Takano, K., Nishino, I., Sakai, T., & Endo, T. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab116 · Cited by 16
Krapacher, F. A., Fernández‐Suárez, D., Andersson, A. K., Carrier‐Ruiz, A., & Ibáñez, C. F. (2022) · The EMBO Journal · doi:10.15252/embj.2022110721 · Cited by 16
“The main downstream effectors of activated TGF b superfamily receptors are the Smad proteins (Derynck & Budi, 2019).”
The E3 Ligases in Cervical Cancer and Endometrial Cancer
Zhai, F., Wang, J., Yang, W., Ye, M., & Jin, X. (2022) · Cancers · doi:10.3390/cancers14215354 · Cited by 16
Madsen, S. F., Sand, J. M. B., Juhl, P., Karsdal, M. A., Thudium, C. S., Siebuhr, A. S., & Bay‐Jensen, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-36416-6 · Cited by 19
Zeng, K.-F., Wang, H., Deng, B., Chen, T.-F., Chen, J.-B., Ding, W.-J., Chen, S., Xie, J.-D., Lu, S.-M., Chen, G.-H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155118 · Cited by 17
TGF ‐β signaling pathway in spinal cord injury: Mechanisms and therapeutic potential
Ma, C.-W., Wang, Z., Ran, R., Liao, H.-Y., Lyu, J.-Y., Ren, Y., Lei, Z., & Zhang, H.-H. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25255 · Cited by 17
“Smad protein is the main TGF-β signal transduction factor, considered as the primary substrate of TGF-β RI phosphorylation, in which TGF-β RI phosphorylates Smad2, and 3 after TGF-β binds to TGF-β RII (Derynck & Budi, 2019).”
BackgroundTarrass, M. A., Belmudes, L., Koça, D., Azemard, V., Liu, H., Tabosh, T. A., Ciais, D., Desroches‐Castan, A., Battail, C., Couté, Y., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01486-0 · Cited by 16
“Over the past two decades, various experimental findings have indicated that ligands belonging to the TGF-β family can activate, in addition to the well-studied canonical SMAD signaling pathway, non-canonical signaling pathways [5–7].”
BackgroundByun, K.-A., Lee, J. H., Lee, S. Y., Oh, S., Batsukh, S., Cheon, G. W., Lee, D., Hong, J. H., Son, K. H., & Byun, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137232 · Cited by 17
“TGF-β , a key regulator of skin aging processes, plays a significant role in upregulating the PI3K/AKT/mTOR pathway [56,57], leading to the phosphorylation of S6K and 4EBP1 [58].”
BackgroundYe, L., Huang, J., Liang, X., Guo, W., Sun, X., Shao, C., He, Y., & Zhang, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155916 · Cited by 16
Janus, P., Kuś, P., Jaksik, R., Vydra, N., Toma-Jonik, A., Gramatyka, M., Kurpas, M. K., Kimmel, M., & Widłak, W. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01821-5 · Cited by 16
“The net activation of SMAD-dependent and SMAD-independent pathways, and the interactions derived from the presence or absence of other parallel signaling cascades determine the functional response to TGFβ [7].”
BackgroundLi, S., Yan, L., Li, C., Lou, L., Cui, F., Yang, X., He, F., & Jiang, Y. (2025) · Nature Communications · doi:10.1038/s41467-024-55788-5 · Cited by 16
Liu, H., & Jiang, B. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-0001-5 · Cited by 16
“Smad signaling pathway is reported to function as an important regulator in the transduction of TGF-b (Derynck and Budi 2019; Itoh and ten Dijke 2007).”
BackgroundGalarza, T. E., Delgado, M. A. T., Mohamad, N. A., Martín, G., & Cricco, G. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114177 · Cited by 16
Zhang, G., Chen, W.-Y., Li, X., Ke, H., & Zhou, X.-L. (2021) · Open Life Sciences · doi:10.1515/biol-2021-0085 · Cited by 16
“Activated TGF-β receptor I phosphorylates two different smad proteins in the case of TGF-β, smad2 and smad3 [10].”
BackgroundLatent TGFβ-binding proteins regulate UCP1 expression and function via TGFβ2
Halbgebauer, D., Roos, J., Funcke, J., Neubauer, H., Hamilton, B. S., Simon, E., Amri, E., Debatin, K., Wabitsch, M., Fischer‐Posovszky, P., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101336 · Cited by 16
GARP: A Key Target to Evaluate Tumor Immunosuppressive Microenvironment
Bouchard, A., Collin, B., Garrido, C., Bellaye, P., & Kohli, É. (2021) · Biology · doi:10.3390/biology10090836 · Cited by 16
Li, B., Cheng, X., Aierken, A., Du, J., He, W., Zhang, M., Tan, N., Kou, Z., Peng, S., Jia, W., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722365 · Cited by 16
Nie, X., Yu, Q., Li, L., Yi, M., Wu, B., Huang, Y., Zhang, Y., Han, H., & Yuan, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.808576 · Cited by 16
“The transforming growth factor-β (TGF-β) signaling pathway family is the core member that maintains the dynamic balance of tissues and organs, and plays a vital role in regulating cell proliferation, differentiation, migration or death (Derynck and Budi 2019; Dituri et al., 2019; Katsuno et al., 2019).”
BackgroundYe, Z., Kilic, G., Dabelsteen, S., Marinova, I. N., Thøfner, J. F. B., Song, M., Rudjord-Levann, A. M., Bagdonaite, I., Vakhrushev, S. Y., Brakebusch, C., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abo2206 · Cited by 16
“This is in accordance with the known inhibitory effect of TGF-β signaling on keratinocyte proliferation (4) and thus confirms the necessity of TGF-β1, TGFβRII, and SMAD4 for the epidermal block in proliferation in KO human skin–like tissue.”
ResultGélabert, C., Papoutsoglou, P., Golán, I., Ahlström, E., Ameur, A., Heldin, C., Caja, L., & Moustakas, A. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01273-3 · Cited by 16
“In contrast, the I-Smads quench the activation of the pathway, thus fine-tuning TGFβ signaling [2, 5].”
BackgroundRegulation and therapeutic potentials of microRNAs to non-small cell lung cancer
Le, M. T., Nguyen, H.-T., Nguyen, X., Do, X.-H., Nguyễn, T. T. B., Nguyen, H. T. N., Than, U. T. T., & Nguyen, T. H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22080 · Cited by 15
How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva
Srinivasan, D., Arostegui, M., Goebel, E. J., Hart, K. N., Aykul, S., Lees‐Shepard, J. B., Idone, V. J., Hatsell, S. J., & Economides, A. N. (2024) · Biomolecules · doi:10.3390/biom14010101 · Cited by 17
“The fact that dimerization of a type I receptor was adequate for signaling appeared contradictory to the well-established understanding that type II receptors (and their kinase activity) are required for signaling [52–54].”
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Odackal, J., Yu, V., Gomez-Manjerres, D., Field, J. J., Burdick, M. D., & Mehrad, B. (2020) · ERJ Open Research · doi:10.1183/23120541.00481-2020 · Cited by 15
“phosphorylated Smad-2 and -3, evidence for TGF-beta receptor signaling in these cells [41].”
BackgroundFortilin interacts with TGF-β1 and prevents TGF-β receptor activation
Pinkaew, D., Martı́nez-Hackert, E., Jia, W., King, M. D., Miao, F., Enger, N. R., Silakit, R., Ramana, K. V., Chen, S., & Fujise, K. (2022) · Communications Biology · doi:10.1038/s42003-022-03112-6 · Cited by 14
MIR503HG: A potential diagnostic and therapeutic target in human diseases
Han, X., Li, B., & Zhang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114314 · Cited by 16
PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
Taghehchian, N., Maharati, A., Akhlaghipour, I., Zangouei, A. S., & Moghbeli, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03086-3 · Cited by 15
Li, C., Zhang, S., Chen, X., Ji, J., Yang, W., Gui, T., Gai, Z., & Li, Y. (2020) · Communications Biology · doi:10.1038/s42003-020-1058-2 · Cited by 15
Mendoza, F. A., & Jiménez, S. A. (2021) · Rheumatology · doi:10.1093/rheumatology/keab762 · Cited by 14
Volatier, T. L. A., Schumacher, B., Meshko, B., Hadrian, K., Cursiefen, C., & Notara, M. (2023) · Biology · doi:10.3390/biology12020265 · Cited by 13
“BMPs and the Smad-family proteins have varied functions, making the exact effects of the changes observed here uncertain [56,57].”
Guo, H., Li, J., Wang, Y., Cao, X., Lv, X., Yang, Z., & Chen, Z. (2023) · Genes · doi:10.3390/genes14061163 · Cited by 14
“The TGF-β family includes TGF-β1, TGF-β2, and TGF-β3 [25], among which TGFβ1 is the most extensively studied and is known to be involved in cell proliferation, cell differentiation, apoptosis, and extracellular matrix (ECM) synthesis.”
BackgroundFeng, Y., Zhao, M., Wang, L., Li, L., Lei, J. H., Zhou, J., Chen, J., Wu, Y., Miao, K., & Deng, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-023-06406-7 · Cited by 14
Dysregulation of deubiquitination in breast cancer
Kong, L., & Jin, X. (2024) · Gene · doi:10.1016/j.gene.2024.148175 · Cited by 15
Targeting the TGF-β signaling pathway: an updated patent review (2021–present)
Guo, W., Liu, H., Yan, Y., Wu, D., Yao, H., Lin, K., & Li, X. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2346325 · Cited by 14
“For example, Bullough et al. from Thirona Bio, Inc. discovered an ALK5 inhibitor 756097, which is a 2-[4-methyl- 1-(6-methylpyridin-2-yl)-1 H-pyrazol-5-yl]thieno[3,2-c]pyridine with an IC 50 of 7 nM.”
BackgroundLiang, R., Lu, H., Zhu, H., Liang, G., Zhang, J., Gao, J., & Tian, T. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.022 · Cited by 16
Yan, W., Rao, D., Fan, F., Liang, H., Zhang, Z., & Dong, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1407434 · Cited by 16
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 14
Mwaura, A. N., Riaz, M. A., Maoga, J. B., Mecha, E. O., Omwandho, C. O. A., Scheiner‐Bobis, G., Meinhold-Heerlein, I. M., & Konrad, L. (2022) · Biology · doi:10.3390/biology11040513 · Cited by 14
Mechanisms and clinical significance of TGF-β in hepatocellular cancer progression
Zaidi, S., Gough, N. R., & Mishra, L. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.02.002 · Cited by 15
Wang, H., Wang, M., Wen, Y., Xu, Z., Chen, X., Wu, D., Su, P., Zhou, W., Cheng, T., Shi, L., et al. (2020) · Advanced Science · doi:10.1002/advs.202001019 · Cited by 14
Intra‐epithelial non‐canonical Activin A signaling safeguards prostate progenitor quiescence
Cambuli, F., Foletto, V., Alaimo, A., Felice, D. D., Gandolfi, F., Palumbieri, M. D., Zaffagni, M., Genovesi, S., Lorenzoni, M., Celotti, M., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154049 · Cited by 14
Mu, Y., Wallenius, A., Zang, G., Zhu, S., Rudolfsson, S. H., Aripaka, K., Bergh, A. R. J., Mateus, A., & Landström, M. (2024) · Oncogene · doi:10.1038/s41388-024-03165-3 · Cited by 14
Lin, S., Liu, D., Liang, T., Zhuang, Y., Wang, X., Ma, S., Li, Q., & Hu, K. (2025) · BMC Medicine · doi:10.1186/s12916-025-03926-1 · Cited by 14
“The TGF-β family comprises three isoforms, namely TGF-β1, TGF-β2, and TGF-β3, existing as homodimers within the biological system [39].”
Cao, J., Hang, K., Zhang, H., Xia, Q., Zhang, X., Men, J., Tian, J., Xia, Z.-L., Liao, D.-S., & Li, K.-Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1601908 · Cited by 15
Gupta, S., Martin, L. M., Sinha, N. R., Smith, K. E., Sinha, P. R., Dailey, E. M., Hesemann, N. P., & Mohan, R. R. (2020) · PubMed Central · Cited by 13
Takahashi, M., Hashimoto, Y., & Nakamura, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.001 · Cited by 13
“INTRODUCTION Transforming growth factor b (TGF-b) is a pleiotropic cytokine involved in diverse cellular events, including cell proliferation, differentiation, immune response, and apoptosis.(1,2) In mammals, there are three isoforms of TGF-b—TGF-b1, -b2, and -b3—encoded at distinct genomic loci,(3) and TGF-b1 is the…”
BackgroundPotential role of TGFΒ and autophagy in early cerebellum development
Dalvand, A., Rosa, S. C. D. S., Ghavami, S., & Marzban, H. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101358 · Cited by 13
Chen, S.-Y. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.01.03 · Cited by 14
A TGF-β– and p63-Responsive Enhancer Regulates IFN-κ Expression in Human Keratinocytes
Klein, K., Habiger, C., Iftner, T., & Stubenrauch, F. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901178 · Cited by 13
Bozhokin, M. S., Sopova, J. V., Kachkin, D. V., Rubel, A. A., & Георгиевич, Х. М. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920040045 · Cited by 13
An, X., Cao, H., Liu, S., & Cao, B. (2021) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2021.106750 · Cited by 13
Lecoutre, S., Merabtene, F., HACHEM, E.-K., Gamblin, C., Rouault, C., Sokolovska, N., Soula, H., Lai, W., Blackshear, P., Clément, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101512 · Cited by 11
“Tgfb regulates the expression of ECM genes by activation of SMAD-2/3 downstream of Tgfb receptors [28].”
BackgroundPu, S., Zhang, J., Ren, C., Zhou, H., Wang, Y., Wu, Y., Yang, S., Cao, F., & Zhou, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121772 · Cited by 11
Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology
Hasaniani, N., Nouri, S., Shirzad, M., & Rostami-Mansoor, S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122668 · Cited by 13
Voicu, G., Mocanu, C. A., Safciuc, F., Rebleanu, D., Anghelache, M., Cecoltan, S., Droc, I., Simionescu, M., Mânduțeanu, I., & Călin, M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136355 · Cited by 12
Chiba-Ohkuma, R., Karakida, T., Yamamoto, R., & Yamakoshi, Y. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf104 · Cited by 12
“30 We confirmed that RANKL-induced osteo-clasts release TGF-β and that resorption pits on the β ( + )-”
SMAD-oncoprotein interplay: Potential determining factors in targeted therapies
Li, X., & Feng, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114155 · Cited by 13
A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression
Zhou, K., Zhao, Z., Li, S., Liu, Y., Li, G., & Jiang, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-75574-9 · Cited by 12
Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP/TAZ
Kofler, M., & Kapùs, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_15 · Cited by 12
Advances in biological and targeted therapies for systemic sclerosis
Mulcaire-Jones, E., Low, A. H. L., Domsic, R. T., Whitfield, M. L., & Khanna, D. (2023) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2023.2196009 · Cited by 13
“TGF-β1 must be activated by proteases or integrins and has an anti-inflammatory function [51].”
BackgroundTRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation
Kolliopoulos, C., Chatzopoulos, A., Skandalis, S. S., Heldin, C., & Heldin, P. (2021) · Cancers · doi:10.3390/cancers13051021 · Cited by 11
Luo, W., Li, Y., Zeng, Y. A., Li, Y., Cheng, M., Zhang, C., Li, F., Wu, Y., Huang, C., Yang, X., et al. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad010 · Cited by 13
Exploration the role of INHBA in Hu sheep granulosa cells using RNA-Seq
Bao, Y., Li, X., El-Samahy, M. A., Yang, H., Wang, Z., Yang, F., Yao, X., & Wang, F. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.12.006 · Cited by 12
Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers
Dai, X., Thompson, E. W., & Ostrikov, K. (2022) · Biomolecules · doi:10.3390/biom12121880 · Cited by 11
“While TβRI and TβRII form a hetero-tetramer that harbors serine/threonine protein kinases in the cytoplasmic domain that are activated after binding of the ligand TGFβ, TβRIII functions as a co-receptor to increase the ligand-receptor interaction affinity without catalytic activity [23,24].”
BackgroundTranscriptional network governing extraembryonic endoderm cell fate choice
Pham, P. D., Lu, H., Han, H., Zhou, J. J., Madan, A., Wang, W., Murre, C., & Cho, K. W. Y. (2023) · Developmental Biology · doi:10.1016/j.ydbio.2023.07.002 · Cited by 11
“We propose that it will be crucial to distinguish the respective contributions of canonical and noncanonical BMP signaling pathways (Derynck and Budi, 2019) to the VE gene program.”
BackgroundShekhar, R., Kumari, S., Vergish, S., & Tripathi, P. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2023.12.001 · Cited by 11
Dai, T., Qiu, S., Gao, X., Zhao, C., Ge, Z., Yang, Y., Tang, C., & Feng, S. (2024) · Cancer Science · doi:10.1111/cas.16067 · Cited by 11
“21 44 Our study suggests that circWNK1 regulates SMAD7 expression via a ceRNA mechanism, subsequently influencing TGF-β signaling and tumor progression in GC.”
Cui, X., Zhang, L., Lin, L., Hu, Y., Zhang, M., Sun, B., Zhang, Z., Lu, M., Guan, X., Hao, J., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113574 · Cited by 11
Ramalingam, V., & Hwang, I. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.11.022 · Cited by 11
Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment
Kapoor, S. S., & Zaiss, D. M. W. (2021) · Biomedicines · doi:10.3390/biomedicines10010052 · Cited by 11
“TGFβ is secreted and stored in a latent form and has to be activated locally [58,59].”
BackgroundInoue, M., Nagai‐Yoshioka, Y., Yamasaki, R., Kawamoto, T., Nishihara, T., & Ariyoshi, W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262612 · Cited by 11
“TGF-β 1 binds to serine-threonine kinase receptors type I (T β RI, ALK5) and type II receptor (T β RII), which form a hetero-tetramer that specifically induces phosphorylation of the receptor activate (R) smads such as smad2 and smad3 [30].”
Expression, Polymorphism, and Potential Functional Sites of the BMPR1A Gene in the Sheep Horn
Zhang, G., Chu, M., Yang, H., Li, H., Shi, J., Feng, P., Wang, S., & Pan, Z. (2024) · Genes · doi:10.3390/genes15030376 · Cited by 10
Mechanism of TGF‑β1 inhibiting Kupffer cell immune responses in cholestatic cirrhosis
Qian, J., Jiao, Y., Wang, G., Liu, H., Cao, X., & Yang, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8826 · Cited by 11
“TGF-β1 is associated with polydysplasia and various human diseases, including cancer, fibrosis and autoimmune diseases (21,22).”
BackgroundYan, X., Peng, R., Ni, Y., Chen, L., He, Q., Li, Q., & Zhou, Q. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.04.005 · Cited by 11
Chandiran, K., Suarez-Ramirez, J. E., Hu, Y., Jellison, E. R., Ugur, Z., Low, J. S., McDonald, B., Kaech, S. M., & Cauley, L. S. (2022) · eLife · doi:10.7554/elife.76457 · Cited by 12
“Members of the TGF cytokine family elicit cellular responses via both canonical and noncanonical signaling pathways (Derynck and Budi, 2019).”
BackgroundGraça, A. L., Domingues, R. M. A., Gómez‐Florit, M., & Gomes, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043516 · Cited by 13
“These results might also be related to an upregulation by EVs-derived TGF-β, a potent stimulator of ECM synthesis [58].”
BackgroundInfluentialDefining the Role of Mitochondrial Fission in Corneal Myofibroblast Differentiation
Jeon, K., Kumar, A., Wozniak, K. T., Nehrke, K. W., & Huxlin, K. R. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.4.2 · Cited by 12
Chen, F., Wang, Q., Xiao, M., Lou, D., Wufuer, R., Hu, S., Zhang, Z., Wang, Y., & Zhang, Y. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.025 · Cited by 10
Fang, H., Li, H., Chen, Y., Liu, X., Zhao, J., Ross, R. P., Stanton, C., Chen, W., & Yang, B. K. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104058 · Cited by 10
Chen, Z., Ou, Y., Ye, F., Li, W., Jiang, H., & Liu, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05798-z · Cited by 10
“The TGF-β latent complex binds to TGF-β receptors on the cell membrane, leading to phosphorylation and activation of SMAD2 and SMAD3 (Derynck and Budi 2019).”
BackgroundRole of Protein Phosphatases in Tumor Angiogenesis: Assessing PP1, PP2A, PP2B and PTPs Activity
Fonódi, M., Nagy, L., & Boratkó, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136868 · Cited by 10
“Reversible protein phosphorylation is one of the most common modifications of proteins to regulate their activity, conformation, interacting partners, or cellular fate.”
BackgroundCD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects
Zheng, D., Qin, L., Lv, J., Che, M., He, B., Zheng, Y., Lin, S., Qi, Y., Li, M., Tang, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102020 · Cited by 11
Bertolio, M., la Colla, A. B., Carrea, A., Romo, A., Canziani, G., Echarte, S. M., Campisano, S., Barletta, G. P., Monzón, A. M., Rodríguez, T. M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.690397 · Cited by 11
Zhang, Y., Chang, H., Zhu, H., & Leung, P. C. K. (2022) · The FASEB Journal · doi:10.1096/fj.202200081rr · Cited by 10
Zhao, M., Ding, N., Wang, H., Zu, S., Liu, H., Wen, J., Liu, J., Ge, N., Wang, W., & Zhang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119501 · Cited by 10
“The canonical downstream signal pathway of TGF-β 1 involves the phosphorylation of Smad2/3 [28].”
BackgroundInfluential
Metadata
- Authors
- Derynck, R., & Budi, E. H.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Derynck, Rik
- Venue
- Science Signaling
- Published
- 2019-02-26
- Volume
- 12
- Issue
- 570
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC6800142
- OpenAlex
- W2917714624
- Cited by
- 785
- References
- 347
- Citations by year
- 2026: 83 · 2025: 85 · 2024: 129 · 2023: 118 · 2022: 102 · 2021: 152 · 2020: 77 · 2019: 35
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (RO1-CA63101, RO1-CA136690)
- JDRF (3-APF-2017-392-A-N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Smad proteins, TGF-beta receptor, dual-specificity kinase, signaling crosstalk, non-Smad signaling, cancer, fibrosis, developmental anomalies
- MeSH terms
- Animals, Cell Differentiation, Gene Expression Regulation, Humans, Ligands, Neoplasms, Protein Binding, Signal Transduction, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review